Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

11.61
+0.20001.75%
Post-market: 11.18-0.4300-3.70%18:36 EDT
Volume:121.05K
Turnover:1.38M
Market Cap:152.70M
PE:-1.93
High:11.92
Open:11.27
Low:11.21
Close:11.41
52wk High:16.00
52wk Low:3.39
Shares:13.15M
Float Shares:6.13M
Volume Ratio:0.42
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0077
EPS(LYR):-7.9367
ROE:-90.25%
ROA:-32.01%
PB:1.46
PE(LYR):-1.46

Loading ...

Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
Apr 28, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 03, 2023

Major Issues Report

8-K - Current report